Lymphoma, T-Cell, Peripheral
Showing 9976 - 10000 of >10,000
Advanced Malignant Solid Tumor, HIV Infection, Metastatic Malignant Solid Tumor Trial in United States (Cabozantinib S-malate,
Completed
- Advanced Malignant Solid Neoplasm
- +4 more
- Cabozantinib S-malate
- +2 more
-
La Jolla, California
- +19 more
Dec 14, 2022
Chronic Inflammation, Chronic Pain, Fatigue Trial in Minneapolis (Modified-Release Prednisone, Placebo)
Completed
- Chronic Inflammation
- +3 more
- Modified-Release Prednisone
- Placebo
-
Minneapolis, MinnesotaMinneapolis Veterans Affairs Medical Center
Apr 7, 2022
Type 2 Diabetes Trial in Worldwide (Tirzepatide, Semaglutide)
Completed
- Type 2 Diabetes
-
Birmingham, Alabama
- +126 more
Jan 21, 2022
Aortic Aneurysm, Abdominal Trial in Latham (Ovation™ Abdominal Stent Graft System)
Completed
- Aortic Aneurysm, Abdominal
- Ovation™ Abdominal Stent Graft System
-
Latham, New YorkCommunity Care Physicians
Nov 22, 2021
ctDNA as a Biomarker for Treatment in Advanced NSCLC
Not yet recruiting
- Non-small Cell Lung Cancer
- Immunotherapy
- +2 more
-
Fuzhou, Fujian, China900TH Hospital of Joint Logisti'cs Support Force
Aug 2, 2022
Solid Tumor, Lymphoma Trial in Beijing (Manganese Chloride, Radiotherapy, Chemo-immunotherapy)
Recruiting
- Solid Tumor
- Lymphoma
- Manganese Chloride
- +2 more
-
Beijing, Beijing, ChinaBiotherapeutic Department of Chinese PLA General Hospital
May 4, 2021
Glioblastoma Trial in Rozzano (18F-GE-180 PET, Advanced MRI, Collection of hematopoietic stem cells)
Not yet recruiting
- Glioblastoma
- 18F-GE-180 PET
- +4 more
-
Rozzano, (mi), ItalyIRCCS Istituto Clinico Humanitas
Oct 27, 2023
Small Cell Lung Cancer Trial in Beijing (Chiauranib, Placebo)
Recruiting
- Small Cell Lung Cancer
- Chiauranib
- Placebo
-
Beijing, Beijing, ChinaCancer Hospital, Chinese Academy of Medical Sciences
May 4, 2022
Reactive Hyperemia, Micro RNA, Heart Rate Variability Trial in Copenhagen (Firefighting training exercises with no fire,
Not yet recruiting
- Reactive Hyperemia
- +5 more
- Firefighting training exercises with no fire
- +2 more
-
Copenhagen, DenmarkThe National Research Centre for the Working Environment
Mar 1, 2023
Hematological Malignancies Trial in Philadelphia (radiation, drug, genetic)
Recruiting
- Hematological Malignancies
- Total Body Irradiation
- +6 more
-
Philadelphia, PennsylvaniaThomas Jefferson University
Feb 4, 2022
Lymphoma Trial in Washington, Baltimore (rituximab, sargramostim, EPOCH regimen)
Withdrawn
- Lymphoma
- rituximab
- +7 more
-
Washington, District of Columbia
- +1 more
Oct 19, 2021
Diffuse Large B Cell Lymphoma, Age Over 80 Years Trial in Guangzhou (lenalidomide combined with rituximab)
Recruiting
- Diffuse Large B Cell Lymphoma
- Age Over 80 Years
- lenalidomide combined with rituximab
-
Guangzhou, Guangdong, ChinaGuangdong provincial people's hospital
Nov 5, 2020
Metastatic Cancer, Solid Tumors, Advanced Cancer Trial in United States (ASP9801, Pembrolizumab)
Recruiting
- Metastatic Cancer
- +2 more
- ASP9801
- Pembrolizumab
-
Birmingham, Alabama
- +26 more
Jan 6, 2023
Recurrent Lung Non-Small Cell Carcinoma, Stage IV Lung Cancer AJCC v8 Trial (procedure, drug, biological)
Not yet recruiting
- Recurrent Lung Non-Small Cell Carcinoma
- Stage IV Lung Cancer AJCC v8
- Biospecimen Collection
- +5 more
- (no location specified)
Nov 30, 2022
Polycystic Ovary Syndrome Trial in Jakarta (WJ-MSCs, Secretomes, WJ-MSCs and Secretomes)
Recruiting
- Polycystic Ovary Syndrome
- UC-MSCs
- +3 more
-
Jakarta, IndonesiaPT Prodia StemCell Indonesia
Sep 23, 2022
Diabetic Neuropathy, Painful Trial (Thermal Biofeedback Assisted Relaxation, Discussion with therapist)
Completed
- Diabetic Neuropathy, Painful
- Thermal Biofeedback Assisted Relaxation
- Discussion with therapist
- (no location specified)
Aug 30, 2021
Small Cell Lung Carcinoma Trial in China (Tiragolumab, Atezolizumab, Carboplatin)
Active, not recruiting
- Small Cell Lung Carcinoma
- Tiragolumab
- +4 more
-
Beijing, China
- +15 more
Aug 15, 2022
Follicular Lymphoma, Marginal Zone Lymphoma Trial in Italy, Spain, United States (EO2463, lenalidomide, rituximab)
Recruiting
- Follicular Lymphoma
- Marginal Zone Lymphoma
- EO2463
- +2 more
-
Boston, Massachusetts
- +9 more
Jul 26, 2022
Immune Checkpoint Inhibitor for Non-Small-Cell Lung Cancer and
Recruiting
- Non Small Cell Lung Cancer
- immune therapy
-
Changsha, Hunan, ChinaHunan Cancer Hospital
Jan 5, 2022
Hip Disease Trial in New York (Bupivacaine + dexamethasone, Ultrasound)
Completed
- Hip Disease
- Bupivacaine + dexamethasone
- Ultrasound
-
New York, New YorkHospital of Special Surgery
Jul 26, 2022
Prostate Cancer Trial in New York (PGV-001, Poly-ICLC, CDX-301)
Recruiting
- Prostate Cancer
- PGV-001
- +2 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai (ISMMS)
Aug 10, 2021
Precision Medicine for Stem Cell Transplantation
Not yet recruiting
- Haematopoietic Stem Cell Transplantation
- Blood sample collection
- Bone marrow aspirate
- (no location specified)
Oct 4, 2022
Vibration; Exposure, Muscle Physiology Trial in Istanbul (vibration)
Completed
- Vibration; Exposure
- Muscle Physiology
- vibration
-
Istanbul, TurkeyIstanbul Physical Medicine Rehabilitation Training & Research Ho
Feb 2, 2022
Ann Arbor Stage I Hodgkin Lymphoma, Ann Arbor Stage I Mixed Cellularity Classic Hodgkin Lymphoma, Ann Arbor Stage I Nodular
Recruiting
- Ann Arbor Stage I Hodgkin Lymphoma
- +13 more
- Bleomycin
- +6 more
-
Birmingham, Alabama
- +16 more
Nov 23, 2021
Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors Trial in Shanghai (AL2846 capsules)
Recruiting
- Neurofibromatosis and Malignant Peripheral Nerve Sheath Tumors
- AL2846 capsules
-
Shanghai, Shanghai, ChinaShanghai Ninth People's Hospital, School of Medicine, Shanghai J
Sep 24, 2021